• Learn more about how TBS has been used in clinical setting,  complementing FRAX® and BMD to improve the detection of bone fragilities in patients at risk of fractures.
  • Gain insights into TBS V4 and how it is designed to enhance evaluation capabilities
  • Hear about how TBS V4 represents a significant clinical advancement by offering a broader patient eligibility, and technical interoperability within the radiology practice.

Meet the speakers

Head of Research and Development, Interdisciplinary Center of Bone Diseases at Lausanne University Hospital and CEO & Co-Founder of Medimaps Group

Honorary Professor at Lancaster University Medical School, UK and Senior Director of Clinical Affairs, Research and Innovation at Medimaps Group